Plasmodium Falciparum Infection and Interference with Effective B Cell Memory

恶性疟原虫感染和对有效 B 细胞记忆的干扰

基本信息

项目摘要

DESCRIPTION (provided by applicant): Naturally acquired immunity is critical in modulating morbidity and mortality from falciparum malaria in endemic areas, where some individuals are infected hundreds of times per year. Humoral responses to Plasmodium falciparum (Pf) are a critical component of this immunity, and Pf-specific memory B cells (MBCs) are likely important in the development and maintenance of an effective response. Unfortunately, protection from clinical disease takes many years to develop, during which time children living in endemic areas experience multiple episodes of symptomatic malaria, resulting in over 1 million deaths annually. Why does antimalarial immunity develop so slowly? One potential explanation is that Pf infection interferes with the development of effective B cell memory. An atypical phenotype of MBC, exhibiting evidence for lower affinity maturation and less capacity for differentiation into antibody secreting cells, has recently been described in the blood of HIV infected subjects. Recent studies have demonstrated that people living in malaria endemic areas have elevated frequencies of similar atypical MBCs, but the relationship between Pf exposure and frequencies of atypical MBCs has not been investigated in detail. Moreover, it is unclear what the consequences of these cells are in malaria infected individuals. We hypothesize that frequent exposure to Pf results in the selective diversion of Pf-specific B cells into an atypical MBC phenotype, delaying the acquisition of protective immunity to Pf. We are in a unique position to test this hypothesis, with access to a well characterized cohort of subjects living in an area of high but heterogeneous malaria transmission intensity and established laboratory infrastructure. Pf transmission intensity at our site in Tororo, Uganda ranks among the highest in the world, and preliminary data from this site suggest that affinity of Pf-specific antibody responses may be compromised in this setting. We will test our hypothesis with the following Specific Aims: 1) To measure the association between Pf exposure and enrichment of atypical memory B cells in children living in a high transmission region of Uganda.; and 2) To measure the association between enrichment of atypical memory B cells and serological and parasitological evidence of protective humoral immunity to malaria. We anticipate this study will show that increased exposure to Pf is associated with increased defects in B cell memory, characterized by higher proportions of Pf-specific MBCs showing an atypical phenotype and evidence of reduced Pf-specific antibody affinity and ability to control blood stage parasites. If so, counter to prevailig notions that malaria control efforts will delay the acquisition of immunity, strategies designed to reduce exposure may have a positive impact on immunity. In addition, methods to characterize Pf-specific B cells developed in this study will have broad application for investigating humoral immunity to Pf.
描述(由申请人提供):自然获得的免疫力对于调节恶性疟疾流行地区的发病率和死亡率至关重要,在这些地区,一些人每年被感染数百次。对恶性疟原虫 (Pf) 的体液反应是这种免疫的关键组成部分,而 Pf 特异性记忆 B 细胞 (MBC) 可能在有效反应的形成和维持中发挥重要作用。不幸的是,针对临床疾病的保护需要很多年才能形成,在此期间,生活在流行地区的儿童会经历多次有症状的疟疾发作,每年导致超过 100 万人死亡。为什么抗疟免疫力发展得如此缓慢?一种可能的解释是 Pf 感染会干扰有效 B 细胞记忆的发育。最近在 HIV 感染者的血液中描述了 MBC 的非典型表型,其表现出较低的亲和力成熟和较低的分化为抗体分泌细胞的能力。最近的研究表明,生活在疟疾流行地区的人们出现类似非典型 MBC 的频率较高,但 Pf 暴露与非典型 MBC 频率之间的关系尚未得到详细研究。此外,尚不清楚这些细胞对疟疾感染者有何影响。我们假设频繁接触 Pf 会导致 Pf 特异性 B 细胞选择性转向非典型 MBC 表型,从而延迟获得对 Pf 的保护性免疫。我们处于检验这一假设的独特位置,可以接触到生活在疟疾传播强度高但异质性地区的一组特征明确的受试者,并建立完善的实验室基础设施。我们位于乌干达托罗罗的站点的 Pf 传输强度位居世界最高之列,该站点的初步数据表明,在这种情况下,Pf 特异性抗体反应的亲和力可能会受到损害。我们将通过以下具体目标来检验我们的假设: 1) 测量生活在乌干达高传播地区的儿童中 Pf 暴露与非典型记忆 B 细胞富集之间的关联。 2) 测量非典型记忆 B 细胞的富集与疟疾保护性体液免疫的血清学和寄生虫学证据之间的关联。我们预计这项研究将表明,增加接触 Pf 与 B 细胞记忆缺陷增加相关,其特征是较高比例的 Pf 特异性 MBC 显示非典型表型,以及 Pf 特异性抗体亲和力和控制血期寄生虫能力降低的证据。如果是这样,与疟疾控制工作将延迟获得免疫力的普遍观念相反,旨在 减少接触可能对免疫力产生积极影响。此外,本研究中开发的表征 Pf 特异性 B 细胞的方法将在研究对 Pf 的体液免疫方面具有广泛的应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bryan R Greenhouse其他文献

Bryan R Greenhouse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bryan R Greenhouse', 18)}}的其他基金

Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
儿童时期菌株特异性和菌株超越性抗疟免疫的驱动因素
  • 批准号:
    10190800
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
儿童时期菌株特异性和菌株超越性抗疟免疫的驱动因素
  • 批准号:
    10406294
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
儿童时期菌株特异性和菌株超越性抗疟免疫的驱动因素
  • 批准号:
    10630290
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Mentoring translational scientists in international infectious disease research
指导国际传染病研究中的转化科学家
  • 批准号:
    10320014
  • 财政年份:
    2019
  • 资助金额:
    $ 19.81万
  • 项目类别:
Mentoring translational scientists in international infectious disease research
指导国际传染病研究中的转化科学家
  • 批准号:
    10534671
  • 财政年份:
    2019
  • 资助金额:
    $ 19.81万
  • 项目类别:
Novel serologic assays of P. falciparum exposure for improved surveillance in control and elimination.
恶性疟原虫暴露的新型血清学检测可改善控制和消除监测。
  • 批准号:
    9107071
  • 财政年份:
    2016
  • 资助金额:
    $ 19.81万
  • 项目类别:
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory
恶性疟原虫感染和对有效 B 细胞记忆的干扰
  • 批准号:
    8701920
  • 财政年份:
    2014
  • 资助金额:
    $ 19.81万
  • 项目类别:
Translational Studies of Plasmodium Falciparum Infection Dynamics
恶性疟原虫感染动力学的转化研究
  • 批准号:
    8110476
  • 财政年份:
    2008
  • 资助金额:
    $ 19.81万
  • 项目类别:
Translational Studies of Plasmodium Falciparum Infection Dynamics
恶性疟原虫感染动力学的转化研究
  • 批准号:
    8321055
  • 财政年份:
    2008
  • 资助金额:
    $ 19.81万
  • 项目类别:
Translational Studies of Plasmodium Falciparum Infection Dynamics
恶性疟原虫感染动力学的转化研究
  • 批准号:
    7676157
  • 财政年份:
    2008
  • 资助金额:
    $ 19.81万
  • 项目类别:

相似国自然基金

基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
  • 批准号:
    32360190
  • 批准年份:
    2023
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
  • 批准号:
    32301185
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
  • 批准号:
    82204046
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于新抗原受体可变域的赭曲霉毒素A竞争物与VHH抗体互作的亲和力调控机制
  • 批准号:
    32102067
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
通过靶向溶酶体治疗 COVID-19 的宿主防御小分子开发
  • 批准号:
    10735492
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Broadly neutralizing SARS-CoV-2 peptidic knobs
广泛中和 SARS-CoV-2 肽旋钮
  • 批准号:
    10735902
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Development of antigen multimers for CAR T cell detection and functional profiling
开发用于 CAR T 细胞检测和功能分析的抗原多聚体
  • 批准号:
    10741209
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了